HomeKPTI • NASDAQ
add
Karyopharm Therapeutics Inc
Previous close
$1.14
Day range
$1.13 - $1.19
Year range
$0.62 - $2.67
Market cap
133.02M USD
Avg Volume
1.24M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 33.13M | -14.40% |
Operating expense | 29.55M | -17.71% |
Net income | -37.36M | -9.48% |
Net profit margin | -112.79 | -27.89% |
Earnings per share | -0.32 | -6.67% |
EBITDA | -33.67M | -10.01% |
Effective tax rate | -0.19% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 148.58M | -42.94% |
Total assets | 204.46M | -37.24% |
Total liabilities | 373.41M | 0.66% |
Total equity | -168.96M | — |
Shares outstanding | 117.71M | — |
Price to book | -0.78 | — |
Return on assets | -37.94% | — |
Return on capital | -53.89% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -37.36M | -9.48% |
Cash from operations | -43.72M | -131.23% |
Cash from investing | 21.94M | 167.74% |
Cash from financing | — | — |
Net change in cash | -21.80M | 57.54% |
Free cash flow | -31.27M | -319.75% |
About
Founded
2008
Headquarters
Website
Employees
325